RPLP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.043200E-01
Normal-vs-Stage2
8.215400E-01
Normal-vs-Stage3
3.352800E-01
Normal-vs-Stage4
8.051200E-01
Stage1-vs-Stage2
8.712200E-01
Stage1-vs-Stage3
4.468200E-01
Stage1-vs-Stage4
5.956200E-01
Stage2-vs-Stage3
2.239200E-01
Stage2-vs-Stage4
5.790200E-01
Stage3-vs-Stage4
1.433760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.533200E-01
Normal-vs-AfricanAmerican
3.178200E-01
Normal-vs-Asian
9.471200E-01
Caucasian-vs-AfricanAmerican
3.311400E-01
Caucasian-vs-Asian
6.097400E-01
AfricanAmerican-vs-Asian
3.298800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.700400E-01
Normal-vs-Female
7.527000E-01
Male-vs-Female
5.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.685000E-01
Normal-vs-Age(41-60Yrs)
7.538400E-01
Normal-vs-Age(61-80Yrs)
7.871200E-01
Normal-vs-Age(81-100Yrs)
5.589200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.795800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.718600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.372600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.295000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.044220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.015230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.792000E-01
Normal-vs-Daily Drinker
9.604000E-01
Normal-vs-Weekly Drinker
7.090000E-01
Normal-vs-Occasional Drinker
8.822600E-01
Normal-vs-Social Drinker
7.243400E-01
Non Drinker-vs-Daily Drinker
9.568800E-01
Non Drinker-vs-Weekly Drinker
4.679800E-01
Non Drinker-vs-Occasional Drinker
6.989200E-01
Non Drinker-vs-Social Drinker
3.801400E-01
Daily Drinker-vs-Weekly Drinker
5.256000E-01
Daily Drinker-vs-Occasional Drinker
6.889600E-01
Daily Drinker-vs-Social Drinker
3.991600E-01
Weekly Drinker-vs-Occasional Drinker
3.739800E-01
Weekly Drinker-vs-Social Drinker
2.365800E-01
Occasional Drinker-vs-Social Drinker
6.641600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.075000E-01
Normal-vs-Grade 2
8.226600E-01
Normal-vs-Grade 3
4.653400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.982800E-01
Grade 1-vs-Grade 3
7.130800E-01
Grade 1-vs-Grade 4
5.075000E-01
Grade 2-vs-Grade 3
4.762000E-01
Grade 2-vs-Grade 4
8.226600E-01
Grade 3-vs-Grade 4
4.653400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.419600E-01
Normal-vs-NonDiabetic
8.779400E-01
Diabetic-vs-NonDiabetic
4.749800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.837400E-01
Normal-vs-NoPancreatitis
8.291400E-01
Pancreatitis-vs-NoPancreatitis
7.284200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.292200E-01
Normal-vs-N1
8.091000E-01
N0-vs-N1
6.671400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.905000E-01
Normal-vs-TP53-NonMutant
5.772000E-01
TP53-Mutant-vs-TP53-NonMutant
1.479840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
